CME

CME


Efficacy Data for Bispecific Antibodies in RRMM

March 01, 2024

Host: Sagar Lonial, MD, FACP "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relap